TruaceTracing the truth around AITuesday, September 15, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,419 results
Show filters and sorting

AI gains · 788

72
GainBusiness· Stable· Evidence: Moderate (1 source)

French SMEs using generative AI tools were able to reassess business models and build entrepreneurial resilience during COVID-19 and geopolitical market turbulence.

In a peer-reviewed study published June 25 2024, researchers surveyed 87 SMEs in France about their use of generative AI tools during the COVID-19 pandemic, geopolitical crises, and economic slowdown. Using a pre-tested survey and WarpPLS 7.0 modelling, they tested how generative AI and entrepreneurial orientation relate to entrepreneurial resilience under market turbulence.

Impact 30%49
Evidence 25%95
Scale 20%60
Confidence 15%87
Recency 10%89

Updated Jul 20, 2026 · TRV-2026-0397

72
GainPolicy· Stable· Evidence: Moderate (1 source)

The EU AI Act establishes a risk-based legal framework and EU-wide governance bodies that promote safe and lawful AI while protecting citizens' health, safety and fundamental rights and keeping the European AI industry competitive.

In February 2024 the Council and European Parliament agreed on the AI Act, a risk-based regulation intended to ensure ethical and responsible AI use across the EU single market. The article examines the governance system in the April 2024 version of the text, noting the creation of a European Artificial Intelligence Office and planned Board, advisory forum, scientific panel, and national competent authorities.

Impact 30%49
Evidence 25%95
Scale 20%60
Confidence 15%87
Recency 10%89

Updated Jul 20, 2026 · TRV-2026-0393

72
GainBusiness· Stable· Evidence: Moderate (1 source)

Innovation managers reported generative AI is more likely than traditional AI to make employees' jobs more fulfilling when used in firms' innovation projects.

In mid-2024, researchers reported results from a large-scale survey and follow-up interviews of innovation managers in the USA to assess how AI is actually used in innovation. They found adoption is high and widespread, with AI applied in more than half of surveyed firms' innovation projects and concentrated in the development stage rather than idea or commercialization stages.

Impact 30%49
Evidence 25%95
Scale 20%60
Confidence 15%87
Recency 10%89

Updated Jul 20, 2026 · TRV-2026-0388

72
GainBusiness· Stable· Evidence: Moderate (1 source)

AI automation of tasks is estimated to produce modest aggregate gains of no more than 0.66% TFP growth over 10 years based on task exposure and task-level cost savings.

This peer-reviewed paper models AI's macroeconomic impact as task-level automation and complementarity, using Hulten's theorem to translate the fraction of tasks impacted and average cost savings into GDP and TFP effects. Using existing exposure estimates, it calculates no more than a 0.66% TFP increase over 10 years, then revises down to less than 0.53% after accounting for the shift from easy-to-learn to hard-to-learn tasks.

Impact 30%63
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%89

Updated Jul 20, 2026 · TRV-2026-0378

AI problems · 631

68
ProblemHealth· Newly added· Evidence: Moderate (1 source)

A novel computational solution, termed BioPINN-LM, integrates 2 computational methods for the rapid real-time prediction of aortic wall stress: a physics-informed neural network (PINN) trained with mechanical simulation data to predict wall stress and a multimodal large language model that uses output data from the PINN along with image-based geometry descriptors to provide interpretable risk assessments from both ends of the aorta.

Axial dissections of the thoracic artery are common causes of death in people diagnosed with aortic dissection; however, decisions to intervene on ascending thoracic aortic patients are determined by the size of the ascending thoracic aorta based on its diameter. Diameter-based criteria fail to take into consideration the biomechanical properties of the aorta as well as other characteristics of the patient, and finite element analysis (in determining aortic wall stresses) would ideally address the issues associated with today's diameter-based criteria.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%98

Updated Sep 4, 2026 · TRV-2026-0979

68
ProblemHealth· Newly added· Evidence: Moderate (1 source)

Objective To evaluate the accuracy, text quality, and perceived potential harm of EHR-integrated and LLM-generated hospital courses in pediatric inpatient care during early clinical implementation.

Background Large language model (LLM)-generated hospital courses are increasingly integrated into electronic health records (EHRs), yet their accuracy and safety in pediatric populations remain poorly characterized. Objective To evaluate the accuracy, text quality, and perceived potential harm of EHR-integrated and LLM-generated hospital courses in pediatric inpatient care during early clinical implementation.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%98

Updated Sep 4, 2026 · TRV-2026-0977

68
ProblemHealth· Newly added· Evidence: Moderate (1 source)

Artificial intelligence and ultra-high performance computing methods and experiments for drug discovery: virtual screening, deep learning, molecular dynamics simulations, ADMET modelling, and experimental validation: Furthermore, advancements in deep learning methodologies are required to improve the accuracy of prediction concerning target functionalities and ligand characteristics, even when complete receptor structures are not available.

Recent years have witnessed considerable progress in computer-aided drug discovery, driven by the incorporation of computational technologies within both academic and pharmaceutical environments. This evolution is marked by a significant accumulation of data pertaining to detailed three-dimensional structural information, ligand properties, and their interactions with therapeutic targets.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%98

Updated Sep 4, 2026 · TRV-2026-0976

68
ProblemHealth· Newly added· Evidence: Moderate (1 source)

Machine learning can enhance risk detection accuracy and support proactive management of complications.

Background Renal transplantation is the preferred treatment for end-stage chronic kidney disease but requires lifelong immunosuppression, increasing the risk of infections such as urinary tract infection (UTI). UTI in kidney transplant recipients can lead to serious complications, including acute kidney injury, reduced graft survival, and increased mortality.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%98

Updated Sep 3, 2026 · TRV-2026-0974

Recomputed live from the record · Sep 15, 2026, 11:36 PM